10 Buy Signals Emerge with High Confidence in September 2026

High-Confidence Buy Signals Surface Across Diverse Stocks This September

As September 2026 draws to a close, the OpportunityRadar scanner has identified a compelling set of 'BUY' signals across the market. Leading the pack are Novavax, Inc. (NVAX) and Teva Pharmaceutical Industries (TEVA), both registering an impressive 100% confidence rating for their 'BUY' signals and designated as 'STRONG ENTRY' opportunities. NVAX stands out with an OpportunityRadar Score of 64, driven by a strong technical score of 73, while TEVA also boasts a Score of 62. Notably, Marathon Petroleum Corporation (MPC) has demonstrated significant price appreciation, with a 3-month return of 48.57%, alongside a 'BUY' signal and an OpportunityRadar Score of 63.

A deeper dive into today's scan reveals a consistent 'BUY' signal across all 15 identified tickers. Among them, six tickers, including NVAX and TEVA from our top 10, achieved the highest possible 100% confidence rating for their entry signals. The technical landscape shows a mixed picture, with eight tickers displaying a 'MACD BULL' signal, indicating upward momentum, while others suggest potential consolidation. The average Relative Strength Index (RSI) across the top 10 featured stocks sits at approximately 54.63, suggesting a generally balanced price strength without immediate signs of being significantly overbought or oversold.

Top 10 Signals at a Glance

#1: NVAX — Novavax, Inc.

Novavax, Inc. (NVAX) emerges as a high-conviction 'STRONG ENTRY' with an OpportunityRadar Score of 64, backed by a robust technical score of 73 and an impressive 100% confidence rating. The stock is currently priced at $10.61. Technical indicators show a Relative Strength Index (RSI) of 64.6, suggesting strong buying interest without being overtly overbought, complemented by a 'MACD BULL' signal. NVAX has demonstrated solid recent performance, posting a 1-month return of 17.29% and a 3-month return of 13.41%.

While the strong technicals and high confidence are compelling, NVAX's Risk/Reward ratio stands at 0.4. This relatively low figure indicates that the potential upside, as defined by the scanner's projected targets, is comparatively small when weighed against the downside risk to the scanner's stop level. Investors monitoring NVAX would consider this ratio in their assessment of the overall opportunity.

#2: CNH — CNH Industrial N.V.

CNH Industrial N.V. (CNH) registers an OpportunityRadar Score of 64, with its technical score at 68 and fundamental score at 58. The scanner issues a 'BUY' signal with a 67% confidence rating and an 'ENTRY' recommendation at its current price of $13.14. The RSI for CNH is 53.5, indicating neutral to slightly positive price momentum. The stock has delivered a 1-month return of 14.96% and a 3-month return of 15.36%, reflecting consistent upward movement over the past few months.

Despite the 'BUY' signal, CNH presents a 'MACD BEAR' indication, which suggests a potential short-term bearish crossover or downward pressure in momentum. This divergence between the overall 'BUY' signal and the MACD status warrants attention, as it could signal a period of consolidation or a temporary pause in its upward trajectory. The Risk/Reward ratio for CNH is 1.0, suggesting an equal balance between potential gains and losses based on the scanner's parameters.

#3: MPC — Marathon Petroleum Corporation

Marathon Petroleum Corporation (MPC) is flagged with a 'BUY' signal and an 'ENTRY' recommendation, holding an OpportunityRadar Score of 63, comprising a technical score of 66 and a fundamental score of 58. Trading at $385.12, MPC has shown remarkable strength over the longer term, with a substantial 3-month return of 48.57%. Its 1-month return stands at 5.94%, indicating continued, albeit slower, recent gains. The stock's RSI is 51.3, suggesting a balanced price strength.

A notable point of caution for MPC is its 'MACD BEAR' signal, which contrasts with the overall 'BUY' recommendation. This technical divergence could imply that while the stock has experienced significant long-term gains, short-term momentum may be waning or undergoing a corrective phase. Furthermore, although the 3-month return is strong, the 1-month return is considerably lower, suggesting a deceleration in its recent performance. The Risk/Reward ratio is 1.6, indicating potential for greater upside than downside.

#4: YPF — YPF Sociedad Anonima

YPF Sociedad Anonima (YPF) receives a 'BUY' signal with a 67% confidence rating and an 'ENTRY' status, driven by an OpportunityRadar Score of 63 (technical score 68, fundamental score 55). The stock is priced at $52.07. YPF's RSI is 45.7, which is below the neutral 50 level, suggesting that the stock may be experiencing some recent weakness or consolidation. Its 1-month return is 3.15%, and its 3-month return is 15.07%, reflecting steady, if not explosive, growth over the quarter.

The 'MACD BEAR' signal for YPF is a key factor to consider, as it points to a potential downtrend in momentum, despite the overarching 'BUY' signal. This could indicate that the stock is undergoing a period of price retracement or consolidation. The lower RSI further supports the idea of recent price softness. However, the Risk/Reward ratio of 2.0 is among the highest in today's scan, suggesting a favorable potential upside relative to risk.

#5: DSX — Diana Shipping inc.

Diana Shipping inc. (DSX) is highlighted with a 'STRONG ENTRY' signal and an 83% confidence rating, achieving an OpportunityRadar Score of 63, with a technical score of 72 and a fundamental score of 50. The stock trades at $2.83. DSX has shown impressive price appreciation over the past three months, with a 3-month return of 40.9%, while its 1-month return stands at 5.28%. The RSI is 49.4, indicating a relatively neutral price momentum.

A significant observation for DSX is the 'MACD BEAR' signal, which presents a potential conflict with the 'STRONG ENTRY' recommendation. This bearish MACD suggests that recent price action might be experiencing a downward shift in momentum, even as the broader signal remains positive. Investors would likely monitor this technical divergence closely. The Risk/Reward ratio of 1.9 is favorable, suggesting a good balance of potential gain versus risk.

#6: TEVA — Teva Pharmaceutical Industries

Teva Pharmaceutical Industries (TEVA) is identified as a 'STRONG ENTRY' with a perfect 100% confidence rating and an OpportunityRadar Score of 62 (technical 65, fundamental 58). Trading at $39.08, TEVA's technical posture is supported by a 'MACD BULL' signal and an RSI of 56.8, indicating healthy upward momentum. The stock has delivered a 1-month return of 3.87% and a robust 3-month return of 17.31%, reflecting consistent performance.

Despite the strong confidence and 'MACD BULL' signal, TEVA exhibits a low Risk/Reward ratio of 0.4. This metric implies that the potential for further gains, as defined by the scanner's targets, is limited compared to the potential downside risk. While the overall signal is very strong, the low Risk/Reward ratio suggests that the entry might be closer to its immediate upside potential, or that the stop loss is relatively tight.

#7: IQV — IQVIA Holdings, Inc.

IQVIA Holdings, Inc. (IQV) shows an OpportunityRadar Score of 62, with a technical score of 65 and a fundamental score of 58. The scanner issues a 'BUY' signal with a 67% confidence rating and an 'ENTRY' recommendation at its current price of $271.98. IQV has demonstrated significant price strength over the quarter, with a 3-month return of 40.72%, and a 1-month return of 3.66%. Its RSI is 62.7, indicating strong recent upward price movement.

A point of consideration for IQV is the 'MACD BEAR' signal, which could suggest a recent shift in short-term momentum despite the strong longer-term price appreciation and 'BUY' signal. Additionally, an RSI of 62.7, while not overbought, positions the stock in the upper range of its typical movement, which could precede a period of consolidation. The Risk/Reward ratio is 1.2, suggesting a reasonable balance between potential gains and losses.

#8: WOR — Worthington Enterprises, Inc.

Worthington Enterprises, Inc. (WOR) registers an OpportunityRadar Score of 62, supported by a technical score of 66 and a fundamental score of 56. The scanner rates WOR as a 'STRONG ENTRY' with an 83% confidence level at its price of $60.61. Technical indicators are favorable, with a 'MACD BULL' signal and an RSI of 57.4, both pointing to positive momentum. The stock has posted a 1-month return of 4.88% and a 3-month return of 12.72%, indicating steady growth.

WOR's data presents a relatively clean picture with strong technical alignment and good confidence. The Risk/Reward ratio is 1.1, suggesting a slightly favorable balance of potential upside to downside risk. While the confidence level is not the absolute highest at 100%, the 83% rating for a 'STRONG ENTRY' combined with bullish MACD and moderate RSI suggests a well-supported signal, with no immediate red flags evident in the provided data.

#9: USEA — United Maritime Corporation

United Maritime Corporation (USEA) receives a 'BUY' signal with a 67% confidence rating and an 'ENTRY' recommendation. Its OpportunityRadar Score is 62, composed of a technical score of 70 and a fundamental score of 50. Trading at $2.81, USEA's RSI is 42.1, indicating that the stock has experienced some recent price weakness, placing it below the neutral 50 level. The stock's returns include a 1-month gain of 2.75% and a 3-month gain of 6.65%.

USEA's 'MACD BEAR' signal, coupled with an RSI below 50, suggests that the stock is currently facing downward momentum or consolidation, despite the overall 'BUY' signal. This divergence between the signal and the momentum indicators warrants careful observation. However, the Risk/Reward ratio of 2.0 is highly favorable, suggesting a significant potential upside if the 'BUY' signal proves accurate, outweighing the current technical headwinds.

#10: SBC — SBC Medical Group Holdings Inc

SBC Medical Group Holdings Inc (SBC) is identified with a 'BUY' signal and an 'ENTRY' recommendation, holding an OpportunityRadar Score of 61 (technical 66, fundamental 53). Priced at $4.78, SBC has demonstrated exceptional performance over the past three months, with a staggering 3-month return of 51.75%. Its 1-month return is also strong at 16.3%. The stock's RSI is 62.8, indicating robust recent price appreciation.

Similar to several other tickers on this list, SBC shows a 'MACD BEAR' signal despite the 'BUY' recommendation and impressive returns. This suggests that while the stock has seen significant gains, short-term momentum might be turning bearish or undergoing a correction. Additionally, an RSI of 62.8 is approaching the upper range, which could indicate that the stock is becoming overextended in the short term. The Risk/Reward ratio is 1.1, offering a balanced outlook.

Key Observations Across the Scan

• High Confidence Entries: Six of the fifteen scanned tickers, including Novavax, Inc. (NVAX) and Teva Pharmaceutical Industries (TEVA) from our top 10, were flagged with a 100% confidence rating for their 'BUY' signals, indicating strong alignment across the scanner's confirmation factors.
• Bullish MACD Signals: Eight of the fifteen tickers, including NVAX, TEVA, and Worthington Enterprises, Inc. (WOR) from the top 10, show a 'MACD BULL' signal, suggesting positive short-term momentum.
• Strong 3-Month Returns: A significant number of tickers have posted substantial 3-month returns, with SBC Medical Group Holdings Inc (SBC) leading the top 10 at 51.75%, followed closely by Marathon Petroleum Corporation (MPC) at 48.57% and Diana Shipping inc. (DSX) at 40.9%.
• Consistent 'BUY' Signals: All 15 tickers identified by the OpportunityRadar scanner today registered a 'BUY' signal, highlighting a broad positive sentiment identified by the system.
• Average RSI: The average RSI for the top 10 profiled stocks is approximately 54.63, indicating a generally neutral to moderately strong price momentum across the group.

Key Risk Factors

1. MACD Divergence: Several tickers, including CNH Industrial N.V. (CNH), Marathon Petroleum Corporation (MPC), and SBC Medical Group Holdings Inc (SBC), present a 'MACD BEAR' signal despite receiving an overall 'BUY' recommendation. This divergence suggests that while the broader signal is positive, short-term momentum may be turning negative or consolidating, which could lead to price volatility.
2. Lower Risk/Reward Ratios: Novavax, Inc. (NVAX) and Teva Pharmaceutical Industries (TEVA), despite their 100% confidence 'STRONG ENTRY' signals, exhibit relatively low Risk/Reward ratios of 0.4. West Pharmaceutical Services (WST), outside the top 10 but with 100% confidence, shows an even lower 0.3 R/R. This implies that the potential upside, as calculated by the scanner, might be limited compared to the defined downside risk.
3. RSI Nearing Upper Range: Some stocks, such as Novavax, Inc. (NVAX) with an RSI of 64.6, IQVIA Holdings, Inc. (IQV) at 62.7, and SBC Medical Group Holdings Inc (SBC) at 62.8, have RSIs above 60. While not definitively overbought (typically above 70), these higher RSI levels suggest that the stocks have experienced significant recent price strength, which could potentially lead to short-term pullbacks or consolidation as buyers take profits.

About Our Methodology

OpportunityRadar scans 6,600+ US stocks daily using 15+ technical indicators including RSI, MACD, Bollinger Bands, ADX, Aroon, support/resistance levels, and volume analysis, combined with fundamental metrics. Stocks are scored 0-100 with signals ranging from Accumulate to Strong Buy. Entry confidence is rated 50-100% based on 6 confirmation factors.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. Past performance does not guarantee future results. Always conduct your own research and consult a qualified financial advisor before making investment decisions. Data as of September 25, 2026.